Piramal Enterprises Investor Relations Material
Latest events
Q4 24/25
Piramal Enterprises
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Piramal Enterprises Limited
Access all reports
Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It offers various financial solutions, such as structured finance solutions in real estate sector; and fixed income securities in housing finance sector. The company also operates as a contract development and manufacturing organization (CDMO) for generic active pharmaceutical ingredients (APIs) and formulations products. In addition, it provides customized research solutions for the pharmaceutical and biotechnology industries.
Key slides for Piramal Enterprises Limited
Q4 24/25
Piramal Enterprises Limited
Q3 24/25
Piramal Enterprises Limited
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
PEL
Country
🇮🇳 India